Novozymes (OTC:NVZMY) reported its Q4 earnings results on Thursday, February 1, 2024 at 03:00 AM.
Here's what investors need to know about the announcement.
Earnings
Novozymes missed estimated earnings by 18.18%, reporting an EPS of $0.36 versus an estimate of $0.44.
Revenue was up $58.13 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.07 which was followed by a 2.66% increase in the share price the next day.
Here's a look at Novozymes's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.42 | 0.42 | 0.44 | 0.41 |
| EPS Actual | 0.49 | 0.32 | 0.41 | 0.43 |
| Revenue Estimate | 634.28M | 632.02M | 662.60M | 671.94M |
| Revenue Actual | 650.51M | 616.52M | 666.31M | 606.10M |
To track all earnings releases for Novozymes visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
